Atelerix Ltd.

Atelerix Ltd.

Private
Newcastle upon TyneHealthcare & Life Scienceshttps://atelerix.co.uk

Last Round

Corporate Funding

Apr 15, 2026

Total Funding Raised

$2.23M

Momentum Score

50 /100

Company Overview

Atelerix Ltd. is a biotechnology company that provides patented hydrogel technology for the storage and transport of cells and tissues at room temperature.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Pharma Supply Chain, Advanced Materials, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

alginate hydrogelcell preservationambient temperature transportcryopreservation alternativelive cell shippingcold chain alternativeroom temperature shippinghydrogel encapsulationtissue preservationdry ice free shippingbiological sample transportcell therapy logisticsbiotech consumablesdrug discovery toolsorganoid transportassay-ready plates

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Atelerix Ltd. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Atelerix Ltd. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingApr 15, 2026
VC RoundJan 28, 2025
Follow-on OfferingMay 14, 2020
Follow-on OfferingMay 9, 2019
SeedApr 30, 2018

Key People

Founding team and executive leadership

Alastair Carrington

Chief Executive Officer

Executive Team

Atelerix Ltd. Investors

Notable investors and investment history

InvestorRounds
ACF InvestorsVC Round
o2h venturesVC Round
UK Innovation & Science Seed FundFollow-on Offering, Seed
Newable Private InvestingSeed, Follow-on Offering

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Launched STORganoid, a cryo-free preservation solution for 3D cell models.

  • Apr 15, 2026

    Completed a corporate funding round.

Atelerix Ltd. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Atelerix Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Atelerix Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNewcastle upon Tyne
Employee Range14
Year Founded2017
Last FundingApr 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.